Researchers from Pritzker Molecular Engineering, under the guidance of Prof. Jeffrey Hubbell, demonstrated that their compound can eliminate the autoimmune response linked to multiple sclerosis. Researchers at the University of Chicago's Pritzker School of Molecular Engineering (PME) have developed

This is fascinating as it works contrary to how most vaccines work. The usual method is to teach the immune system to attack things ( Covid, Polio, Influenza, etc, etc). This does the opposite, it makes the immune system forget to attack things it shouldn’t be attacking. The list of autoimmune diseases is long, and many people suffer from them.

That said, this is only a Phase 1 Clinical trial. That will test if the vaccine is safe, and see what its side-effects are. The journey from amazing lab results to a viable treatment is rocky, and often ends in failure. Still, if this can prove its potential as a treatment it will be revolutionary.

  • engityra@kbin.social
    4·
    1 year ago

    As someone with family members who are type 1 diabetics, I have heard the joke that everyone who gets diagnosed with it is told there will be a cure in 10 years. It’s nice to see they’ve started trials on this at least.

  • OurTragicUniverse@kbin.social
    2·
    1 year ago

    I wonder how expensive this will end up being. I also feel like it will be enshittified into an endless subscription of shots or it’ll stop working or something. We don’t get nice things in this timeline.